Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time

Cotreatment with methotrexate in routine care patients with rheumatoid arthritis receiving biological treatment yields better outcomes over time

Objectives We aimed to evaluate the effects of methotrexate (MTX) comedication added to biological disease-modifying antirheumatic drugs (bDMARD) on disease activity measures in patients with rheumatoid arthritis (RA) in routine care.Methods Patients with RA on treatment with either bDMARDs or conve...

Full description

Saved in:
Bibliographic Details
Main Authors: Niels W. Boone, Alexandre Sepriano, Paul-Hugo van der Kuy, Rob Janknegt, Ralph Peeters, Robert B. M. Landewé
Format: Article
Language:English
Published: BMJ Publishing Group 2019-06-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/5/1/e000836.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items